• <em>GAN</em>-Related Neurodegeneration
• A multilevel screening pipeline in zebrafish identifies therapeutic drugs for GAN
• A New Mouse Model of Giant Axonal Neuropathy with Overt Phenotypes and Neurodegeneration Driven by Neurofilament Disorganization
• Anesthetic Management of Children and Adolescents With Giant Axonal Neuropathy: A Large Case Series
• Axonal Transport Defect in Gigaxonin Deficiency Rescued by Tubastatin A
• Calpain-mediated proteolysis of vimentin filaments is augmented in giant axonal neuropathy fibroblasts exposed to hypotonic stress
• Development of a high-throughput tailored imaging method in zebrafish to understand and treat neuromuscular diseases
• Divergent Molecular Pathways for Toxicity of Selected Mutant C9ORF72-derived Dipeptide Repeats
• Evaluation of hair structural abnormalities in children with different neurological diseases
• Expanding the genetic spectrum of giant axonal neuropathy: Two novel variants in Iranian families
• Genetic Approaches for the Treatment of Giant Axonal Neuropathy
• Giant Axonal Neuropathy
• Giant axonal neuropathy (GAN) in an 8-year-old girl caused by a homozygous pathogenic splicing variant in GAN gene
• Giant Axonal Neuropathy: A Case Report of Subclinical Childhood Manifestations
• Giant axonal neuropathy: The first Iranian case with a variation in the gigaxonin gene and a glance to the other cases
• Gigaxonin is required for intermediate filament transport
• Intermediate filament dysregulation and astrocytopathy in the human disease model of <em>KLHL16</em> mutation in giant axonal neuropathy (GAN)
• Intermediate filament dysregulation and astrocytopathy in the human disease model of KLHL16 mutation in giant axonal neuropathy (GAN)
• Intermediate filament dysregulation in astrocytes in the human disease model of <em>KLHL16</em> mutation in giant axonal neuropathy (GAN)
• Intermediate filament dysregulation in astrocytes in the human disease model of KLHL16 mutation in giant axonal neuropathy (GAN)
• Intrathecal Gene Therapy for Giant Axonal Neuropathy
• Involvement of autonomic nervous system since middle age in elderly patient with giant axonal neuropathy caused by novel genetic mutation
• O-GlcNAcylation and Its Roles in Neurodegenerative Diseases
• Sacsin Deletion Induces Aggregation of Glial Intermediate Filaments
• Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
• The CRL3^gigaxonin ubiquitin ligase-USP15 pathway governs the destruction of neurofilament proteins
• Two novel pathogenic mutations of GAN gene identified in a chinese family with giant axonal neuropathy: a case report